Cell and Gene Therapy GMP Services Market Forecast to Reach $5.88 Billion by 2030, Growing at 18.9% CAGR

September 13, 2026

The Business Research Company Global

Overview

The Business Research Company released a report forecasting the GMP services market for cell and gene therapy to reach $2.95 billion in 2026 and expand to $5.88 billion by 2030, exhibiting an 18.9% CAGR. This growth is primarily driven by an increasing cell therapy pipeline, escalating demand for scalable manufacturing capabilities, and expanding outsourcing to CDMOs.

In Depth

This article provides an overview of a market research report published by The Business Research Company.

Report Overview

This comprehensive market research report focuses on the current status and future projections of the “Good Manufacturing Practice (GMP) Services Market for Cell and Gene Therapy.” The market under review encompasses the entire spectrum of GMP-compliant services related to the manufacturing of cell and gene therapeutics, covering diverse service providers across process development, manufacturing, quality control, and logistics. The report provides a detailed analysis of market trends and growth drivers for the global market from 2026 through 2030.

Key Findings

According to the report, the global GMP services market for cell and gene therapy is expected to be valued at $2.95 billion in 2026. Subsequently, it is projected to achieve a notable Compound Annual Growth Rate (CAGR) of 18.9% through 2030, reaching a market size of $5.88 billion. This robust growth is primarily fueled by the following factors:

Increasing Cell Therapy Pipeline: The global proliferation of cell and gene therapy candidates in clinical development is driving a corresponding expansion in demand for manufacturing services.
Demand for Scalable Manufacturing Capabilities: As therapies approach commercialization, there is a heightened need for scalable and cost-efficient manufacturing solutions to enable large-volume production.
Growing Outsourcing to CDMOs: Many biotechnology companies are opting to outsource manufacturing operations to Contract Development and Manufacturing Organizations (CDMOs) that possess specialized expertise and infrastructure, thereby accelerating development timelines and reducing initial capital investment.

About the Publisher

The Business Research Company is a global market research firm offering detailed market intelligence reports, business intelligence, and consulting services. The company provides extensive data and analysis across various industry sectors, equipping businesses with insights for strategic decision-making.

Source: https://www.thebusinessresearchcompany.com/report/good-manufacturing-practice-gmp-services-for-cell-and-gene-therapy-market-report

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.